Revolution Medicines, Inc.(RVMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

RVMD Revolution Medicines, Inc.

Not Yet Opened 01-20 16:00:00 EST

116.22

-4.06

-3.38%

盘后117.68

+1.46+1.26%

19:58 EST

High119.75	Low113.96	Vol5.31M
Open118.59	D1 Closing120.28	Amplitude4.81%
Mkt Cap22.47B	Tradable Cap19.18B	Total Shares193.32M
T/O616.36M	T/O Rate3.22%	Tradable Shares165.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"RVMD","market":"US","secType":"STK","nameCN":"Revolution Medicines, Inc.","latestPrice":116.22,"timestamp":1768942800000,"preClose":120.28,"halted":0,"volume":5311354,"hourTrading":{"tag":"盘后","latestPrice":117.6805,"preClose":116.22,"latestTime":"19:58 EST","volume":154393,"amount":17943929.9921,"timestamp":1768957101670,"change":1.4605,"changeRate":0.012567,"amplitude":0.015058},"delay":0,"changeRate":-0.033754572663784524,"floatShares":165000000,"shares":193319805,"eps":-5.193111,"marketStatus":"Not Yet Opened","change":-4.06,"latestTime":"01-20 16:00:00 EST","open":118.59,"high":119.75,"low":113.96,"amount":616363935.73392,"amplitude":0.048138,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.193111,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1768986000000},"marketStatusCode":0,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":120.28,"preHourTrading":{"tag":"盘前","latestPrice":118.66,"preClose":120.28,"latestTime":"09:29 EST","volume":12441,"amount":1472389.61298,"timestamp":1768919355046,"change":-1.62,"changeRate":-0.013469,"amplitude":0.03417},"postHourTrading":{"tag":"盘后","latestPrice":117.6805,"preClose":116.22,"latestTime":"19:58 EST","volume":154393,"amount":17943929.9921,"timestamp":1768957101670,"change":1.4605,"changeRate":0.012567,"amplitude":0.015058},"volumeRatio":1.233898,"optionData":{"bulkOrders":[{"symbol":"RVMD","call":false,"expireDate":1771563600000,"strike":"95.0","timestamp":1768930753073,"price":4.2,"volume":2500,"amount":1050000,"type":"+"}]},"impliedVol":0.7921,"impliedVolPercentile":0.9841},"requestUrl":"/m/hq/s/RVMD","defaultTab":"news","newsList":[{"id":"2604111869","title":"Revolution Medicines Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2604111869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604111869?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:22","pubTimestamp":1768918920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RVMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 20, 2026 09:22 ET (14:22 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD"],"gpt_icon":0},{"id":"2604161141","title":"Revolution Medicines Inc : Guggenheim Raises Target Price to $160 From $92","url":"https://stock-news.laohu8.com/highlight/detail?id=2604161141","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604161141?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:48","pubTimestamp":1768916890,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nFWN3YL11X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RVMD"],"gpt_icon":0},{"id":"2604165781","title":"LifeSci Capital Remains a Buy on Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2604165781","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604165781?lang=en_us&edition=fundamental","pubTime":"2026-01-20 21:38","pubTimestamp":1768916283,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Charles Zhu maintained a Buy rating on Revolution Medicines today and set a price target of $144.00. Zhu covers the Healthc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-revolution-medicines-rvmd-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-remains-a-buy-on-revolution-medicines-rvmd-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2603987969","title":"Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD), Ionis Pharmaceuticals (IONS) and DENTSPLY SIRONA (XRAY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603987969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603987969?lang=en_us&edition=fundamental","pubTime":"2026-01-16 20:00","pubTimestamp":1768564841,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Revolution Medicines (RVMD – Research Report), Ion...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-ionis-pharmaceuticals-ions-and-dentsply-sirona-xray-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-revolution-medicines-rvmd-ionis-pharmaceuticals-ions-and-dentsply-sirona-xray-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0128526141.USD","BK4139","LABU","XLV","HCSG","LU0029874061.USD","BK4585","BK4588","IONS","BK4581","XBI","RVMD","XRAY","BK4198"],"gpt_icon":0},{"id":"2603682035","title":"Revolution Medicines Is Maintained at Outperform by Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2603682035","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603682035?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:44","pubTimestamp":1768311840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RVMD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 13, 2026 08:44 ET (13:44 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","MFG"],"gpt_icon":0},{"id":"2603561684","title":"Mizuho Adjusts Price Target on Revolution Medicines to $143 From $90, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2603561684","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603561684?lang=en_us&edition=fundamental","pubTime":"2026-01-13 21:07","pubTimestamp":1768309620,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) has an average rating of buy and mean price target of $91, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RVMD","MFG"],"gpt_icon":0},{"id":"2603689822","title":"Revolution Medicines: Clinical Momentum and Strategic Phase 3 Design Support Buy Rating on RVMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2603689822","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603689822?lang=en_us&edition=fundamental","pubTime":"2026-01-13 20:15","pubTimestamp":1768306545,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Brian Cheng has maintained their bullish stance on RVMD stock, giving a Buy rating today. Brian Cheng has given his Buy rating ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/revolution-medicines-clinical-momentum-and-strategic-phase-3-design-support-buy-rating-on-rvmd-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/revolution-medicines-clinical-momentum-and-strategic-phase-3-design-support-buy-rating-on-rvmd-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD"],"gpt_icon":0},{"id":"2603097845","title":"Analysts Offer Insights on Healthcare Companies: PTC Therapeutics (PTCT), Revolution Medicines (RVMD) and West Pharmaceutical Services (WST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603097845","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603097845?lang=en_us&edition=fundamental","pubTime":"2026-01-13 16:30","pubTimestamp":1768293047,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on PTC Therapeutics (PTCT – Research Report), Revolution Medicines (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ptc-therapeutics-ptct-revolution-medicines-rvmd-and-west-pharmaceutical-services-wst-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ptc-therapeutics-ptct-revolution-medicines-rvmd-and-west-pharmaceutical-services-wst-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","BK4504","LU0345774631.USD","BK4554","LU0345774391.USD","LU0012050646.USD","LU0889565916.HKD","LU1721428347.USD","LU1951198990.SGD","RVMD","LU0106261612.USD","BK4585","LU0320765992.SGD","LU2506952410.USD","PTC","XBI","SG9999014021.USD","BK4576","BK4121","IE00B64QTZ34.USD","HCSG","BK4588","LU0029874061.USD","IE00BYQQ9H92.USD","PTCT","LU1923623000.USD","LU1951200564.SGD","LU2477742899.HKD","LU2362540622.SGD","LU2506952337.HKD","SG9999014005.SGD","BK4137","IE00BFXG0V08.USD","SG9999014013.SGD","BK4567","LU2362541513.USD","WST","BK4139","LU2362541273.HKD","BK4023","BK4581","XLV","LU0128526141.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"2603525150","title":"Revolution Medicines: Dominant Pancreatic Cancer Position, Expanding RAS Franchise, and 2026 Catalyst Funnel Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2603525150","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603525150?lang=en_us&edition=fundamental","pubTime":"2026-01-13 04:35","pubTimestamp":1768250119,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Laura Prendergast has maintained their bullish stance on RVMD stock, giving a Buy rating today. Laura Prendergast has given...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/revolution-medicines-dominant-pancreatic-cancer-position-expanding-ras-franchise-and-2026-catalyst-funnel-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/revolution-medicines-dominant-pancreatic-cancer-position-expanding-ras-franchise-and-2026-catalyst-funnel-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD"],"gpt_icon":0},{"id":"2603752515","title":"$30B ‘might not be enough’ for Revolution Medicines, says Stifel","url":"https://stock-news.laohu8.com/highlight/detail?id=2603752515","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603752515?lang=en_us&edition=fundamental","pubTime":"2026-01-13 04:30","pubTimestamp":1768249813,"startTime":"0","endTime":"0","summary":"After Revolution Medicines (RVMD) presented pipeline updates and its 2026 outlook at a competitor conference in the wake of a report that Merck (MR...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/30b-might-not-be-enough-for-revolution-medicines-says-stifel-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/30b-might-not-be-enough-for-revolution-medicines-says-stifel-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0266013472.USD","LU1917777945.USD","SG9999014559.SGD","LU0265550359.USD","LU0130102774.USD","BK4127","LU0985320562.USD","LU2361045086.USD","BK4534","SG9999014567.USD","LU0098860793.USD","LU1929549753.HKD","LU0477156953.USD","LU0965508806.USD","LU1037948541.HKD","IE00B4R5TH58.HKD","IE00BN8TJ469.HKD","BK4533","SG9999002224.SGD","LU1941712264.USD","LU0006306889.USD","LU1035773651.USD","LU0234572021.USD","LU1934455863.HKD","LU1066051811.HKD","IE00BBT3K403.USD","IE000M9KFDE8.USD","SF","SGXZ57979304.SGD","LU1934455194.USD","LU0648001328.SGD","LU0980610538.SGD","SG9999014575.USD","LU2324357040.USD","LU1066053197.SGD","LU1093756325.SGD","LU0211331839.USD","BK4550","SG9999001440.SGD","IE00BSNM7G36.USD","SG9999001176.SGD","BK4559","LU0106261372.USD","IE00BJJMRZ35.SGD","LU2125154935.USD","BK4007","LU1571399168.USD","IE00BJT1NW94.SGD","LU0965509101.SGD","LU1201861249.SGD","LU0070302665.USD","SG9999015358.SGD","LU2106854487.HKD","LU1069347547.HKD","LU1983299246.USD","IE00BLSP4452.SGD","LU1974910355.USD","IE00B1BXHZ80.USD","LU0208291251.USD","LU1023059063.AUD","LU1989772923.USD","IE00B2B36J28.USD","BK4516","LU0203345920.USD","LU1989772840.SGD","LU2361044949.HKD","LU2361044865.SGD","LU0320765646.SGD","LU1162221912.USD","LU1430594728.SGD","IE00BLSP4239.USD","BK4588","LU1941712348.USD","LU0122379950.USD","SG9999001176.USD","LU0265550946.USD","LU1585245621.USD","LU0238689110.USD","SG9999002232.USD","LU1934455277.USD","LU0965509283.SGD","LU0203347892.USD","LU0861579265.USD","LU1116320901.HKD","LU2461242641.AUD","BK4585","LU0058720904.USD","LU1061106388.HKD","LU1057294990.SGD","LU2468319806.SGD","LU0965509010.AUD","RVMD","LU1116320737.USD","SG9999015341.SGD","LU1066051225.USD","LU1989771016.USD","LU0320765489.SGD","SG9999014542.SGD","LU1291159041.SGD","LU2023250504.SGD","IE0009355771.USD","SG9999013999.USD","LU2360032135.SGD","LU1699723380.USD","BK4139","LU1066051498.USD","LU0130517989.USD","LU2089984988.USD","LU2125154778.USD","LU2023250843.SGD","LU2112291526.USD","LU1093756168.USD","LU1037948897.HKD","IE00BFTCPJ56.SGD","LU0289739699.SGD","IE0002141913.USD"],"gpt_icon":0},{"id":"2603282155","title":"Revolution Medicines CEO says not commenting on ‘rumors or speculation’","url":"https://stock-news.laohu8.com/highlight/detail?id=2603282155","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603282155?lang=en_us&edition=fundamental","pubTime":"2026-01-13 02:55","pubTimestamp":1768244112,"startTime":"0","endTime":"0","summary":"Says 2026 to be year of growing impact for company. Says has “strong” cash position, with $1.9B as of the end of Q3 and an additional $1.75B in com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-ceo-says-not-commenting-on-rumors-or-speculation-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-ceo-says-not-commenting-on-rumors-or-speculation-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2603528260","title":"Revolution Medicines CEO presenting at JPMorgan healthcare conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2603528260","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603528260?lang=en_us&edition=fundamental","pubTime":"2026-01-13 02:45","pubTimestamp":1768243534,"startTime":"0","endTime":"0","summary":"The CEO from Revolution Medicines (RVMD), Mark Goldsmith, is presenting at the JPMorgan Healthcare Conference. Previously, STAT’s Adam Feuerstein h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/revolution-medicines-ceo-presenting-at-jpmorgan-healthcare-conference-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/revolution-medicines-ceo-presenting-at-jpmorgan-healthcare-conference-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234572021.USD","IE00BZ1G4Q59.USD","BK4207","RVMD","LU0149725797.USD","LU2552382132.HKD","LU1119994496.HKD","LU2592432038.USD","IE00BLSP4452.SGD","LU0170899867.USD","LU0496365809.HKD","BK4588","LU1366192091.USD","IE00BLSP4239.USD","LU0211331839.USD","LU0964807845.USD","LU0971096721.USD","LU1496350502.SGD","LABU","LU1551013425.SGD","LU0820561909.HKD","LU0211327993.USD","LU0211328371.USD","LU0683600562.USD","LU1116320901.HKD","LU2264538146.SGD","LU0048584097.USD","XBI","BK4550","IE00BKDWB100.SGD","IE00B1BXHZ80.USD","IE00BYXW3230.USD","LU0417517546.SGD","LU0689472784.USD","LU0942090050.USD","BK4533","LU1720051108.HKD","LU0251132253.USD","LU1894683264.USD","LU2417539215.USD","XLV","LU2505996681.GBP","SG9999002232.USD","LU1670628061.USD","LU1974910355.USD","LU2237443978.SGD","LU2237443465.HKD","LU1032466523.USD","LU2213496289.HKD","LU0215105999.USD"],"gpt_icon":0},{"id":"2603528529","title":"Revolution Medicines Showcases Pipeline Progress and Phase 3 Trials Targeting RAS-Driven Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2603528529","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603528529?lang=en_us&edition=fundamental","pubTime":"2026-01-13 02:35","pubTimestamp":1768242936,"startTime":"0","endTime":"0","summary":"Revolution Medicines Inc. recently provided an update on its clinical pipeline targeting RAS-addicted cancers, highlighting progress across multiple investigational drugs. The company reported that over 2,500 patients have been treated with its RAS inhibitors and that eight randomized Phase 3 registrational trials are active or planned for 2026. Four clinical-stage investigational drugs—daraxonrasib, zoldonrasib, elironrasib, and RMC-5127—are being evaluated for pancreatic, non-small cell lung, and colorectal cancers. Daraxonrasib showed compelling monotherapy results in previously treated patients, as well as encouraging safety and efficacy in combination with pembrolizumab and chemotherapy. Zoldonrasib and elironrasib also demonstrated promising initial safety and antitumor activity in early trials. Registrational trials are ongoing or in advanced planning stages for each candidate, with enrollment completed in key studies for pancreatic cancer and ongoing trials for non-small cell l","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL467W24:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2602559489","title":"Sandisk, Bloom Energy, And Oklo Are Among the Top 10 Large-Cap Gainers Last Week (Jan. 5-Jan. 9): Are the Others in Your Portfolio?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602559489","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602559489?lang=en_us&edition=fundamental","pubTime":"2026-01-11 21:01","pubTimestamp":1768136460,"startTime":"0","endTime":"0","summary":"Defense, AI power demand and deal-driven catalysts powered last week's top large-cap winners, led by sharp surges in RGC, RVMD and a cluster of defense and data-center energy plays.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/11/Oklo.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/11/Oklo.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/01/49831544/sandisk-bloom-energy-and-oklo-are-among-the-top-10-large-cap-gainers-last-week-jan-5-jan-9-are-the-others-in-your-portfolio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/01/49831544/sandisk-bloom-energy-and-oklo-are-among-the-top-10-large-cap-gainers-last-week-jan-5-jan-9-are-the-others-in-your-portfolio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["USJW.SI","LU2294711713.HKD","LU1988902786.USD","LU0476273544.USD","PSQ","LU0444973449.USD","TSYW.SI","AVAV","BK4187","LU2249611893.SGD","LU2264538146.SGD","BK4139","BK4170","MNQmain","LU2506951792.HKD","USAW.SI","NVIW.SI","LU2357125470.USD","SNDK","BK4603","SQQQ","OKLO","LU1815336760.USD","BK4585","KRMN","LU2543165471.USD","LU1642822529.SGD","BK4182","BK4539","BK4588","BK4609","LU0444971666.USD","BK4166","QID","BK4608","LU1064131342.USD","QLD","TQQQ","LU0957808578.USD","BK4541","BK4081","BK4007","NQmain","BK4116","LU0823414551.USD","BK4606","RVMD","FIGR","BK4211","BE","LU0823414478.USD","BK4023"],"gpt_icon":1},{"id":"2602043843","title":"Dow Jones Top Company Headlines at 5 PM ET: Merck in Talks to Buy Revolution Medicines for Around $30 Billion | Meta ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2602043843","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602043843?lang=en_us&edition=fundamental","pubTime":"2026-01-10 06:00","pubTimestamp":1767996000,"startTime":"0","endTime":"0","summary":"Revolution is developing drugs that target a molecular driver of cancers.Meta Unveils Sweeping Nuclear-Power Plan to Fuel Its AI Ambitions. The Facebook parent will back nuclear projects with Oklo, Bill Gates-backed TerraPower, and Vistra.OpenAI, SoftBank to Invest $1 Billion in SB Energy. SoftBank's company is working with OpenAI to help develop its artificial-intelligence infrastructure platform Stargate.Bob's Discount Furniture has filed for its initial public offering, confirming an earlier report by The Wall Street Journal that said Bain Capital was working toward the chain's public debut.Customers with commercial insurance will pay a minimum of $25 for a one-month supply, while the cost for those without insurance starts at $149 a month.Rio Tinto, Glencore Restart Talks to Form World's Biggest Miner. The deal would create a mining company with a market value of more than $200 billion, as a scramble for copper and other metals drives an industry return to big acquisitions.Nvidia H","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"5c3a7bebd9f883eebd19e3bf830267ed","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","LU1066051498.USD","LU0965509101.SGD","LU1941712264.USD","LU0289739699.SGD","LU1989771016.USD","SG9999001176.SGD","MRK","LU1974910355.USD","LU2023250843.SGD","LU1057294990.SGD","LU0980610538.SGD","LU0098860793.USD","LU1066053197.SGD","LU0238689110.USD","LU1989772923.USD","LU0234572021.USD","SG9999014567.USD","LU0130517989.USD","LU1037948541.HKD","IE00BN8TJ469.HKD","BK4144","LU2112291526.USD","RVMD","SG9999002232.USD","LU1934455863.HKD","IE0009355771.USD","LU0106261372.USD","LU1201861249.SGD","BK4588","LU1116320901.HKD","SG9999001176.USD","IE00BBT3K403.USD","LU1061106388.HKD","LU0265550946.USD","LU2089984988.USD","LU1934455194.USD","LU1983299246.USD","LU2324357040.USD","LU0648001328.SGD","LU2361044949.HKD","LU2360032135.SGD","LU1917777945.USD","LU0070302665.USD","LU1037948897.HKD","LU2023250504.SGD","LU0965509283.SGD","LU0265550359.USD","LU1023059063.AUD","LU1571399168.USD","LU0203345920.USD","LU1934455277.USD","BK4007","BK4533","BK4585","LU0266013472.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","LU2125154935.USD","LU2361044865.SGD","LU0320765489.SGD","LU1941712348.USD","LU1066051225.USD","LU2461242641.AUD","IE00BJT1NW94.SGD","LU1585245621.USD","LU1929549753.HKD","BK4139","IE00B1BXHZ80.USD","LU0122379950.USD","SG9999015341.SGD","LU0965508806.USD","LU0965509010.AUD","LU0130102774.USD","LU2361045086.USD","SG9999014575.USD","LU0985320562.USD","SG9999014559.SGD","IE00BSNM7G36.USD","BK4559","LU1093756325.SGD","BK4581","LU1162221912.USD","SG9999014542.SGD","IE00BFTCPJ56.SGD","BK4561","BK4516","LU1035773651.USD","LU2125154778.USD","LU1989772840.SGD","BK4550","IE00B4R5TH58.HKD","LU0208291251.USD","LU0861579265.USD","IE00BLSP4239.USD","LU0203347892.USD","SG9999015358.SGD","LU1291159041.SGD","LU1116320737.USD","LU0320765646.SGD","LU1066051811.HKD","LU1430594728.SGD","SG9999001440.SGD","SGXZ57979304.SGD","BK4534","LU1699723380.USD","IE0002141913.USD","IE00BLSP4452.SGD","IE00B2B36J28.USD","LU2468319806.SGD","META","LU0477156953.USD","SG9999002224.SGD","LU1069347547.HKD","BK4590","LU1093756168.USD","LU0058720904.USD","IE000M9KFDE8.USD","LU0006306889.USD","LU0211331839.USD"],"gpt_icon":1},{"id":"2602561301","title":"Revolution Medicines CFO Jack Anders Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2602561301","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602561301?lang=en_us&edition=fundamental","pubTime":"2026-01-10 05:20","pubTimestamp":1767993657,"startTime":"0","endTime":"0","summary":"Jack Anders, Chief Financial Officer of Revolution Medicines Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revolution Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDLbLbmRx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines CFO Jack Anders Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2602306022","title":"Merck in talks to pay about $30B for Revolution Medicines, WSJ says","url":"https://stock-news.laohu8.com/highlight/detail?id=2602306022","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602306022?lang=en_us&edition=fundamental","pubTime":"2026-01-10 04:10","pubTimestamp":1767989415,"startTime":"0","endTime":"0","summary":"Merck (MRK) is in talks to acquire Revolution Medicines (RVMD) in a deal that could value it at around $30B as the pharma giant has been discussing...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-in-talks-to-pay-about-30b-for-revolution-medicines-wsj-says-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-in-talks-to-pay-about-30b-for-revolution-medicines-wsj-says-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1571399168.USD","LU1941712264.USD","LU0965509010.AUD","LU1983299246.USD","LU0203345920.USD","SG9999014542.SGD","IE0002141913.USD","LU2360032135.SGD","LU1093756325.SGD","LU0203347892.USD","SG9999013999.USD","LU0320765646.SGD","LU1061106388.HKD","LU1974910355.USD","IE00BBT3K403.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","LU2361044949.HKD","LU1430594728.SGD","LU2112291526.USD","SG9999014575.USD","MRK","IE000M9KFDE8.USD","SG9999015341.SGD","BK4559","LU0265550359.USD","LU1037948897.HKD","LU2324357040.USD","IE00BLSP4239.USD","LU0211331839.USD","IE0009355771.USD","LU1699723380.USD","LU0006306889.USD","LU0648001328.SGD","BK4550","SG9999001440.SGD","BK4533","IE00BSNM7G36.USD","SG9999002224.SGD","BK4516","LU1162221912.USD","LU0130517989.USD","LU1934455277.USD","BK4588","LU0985320562.USD","LU2125154778.USD","LU0965509283.SGD","LU1037948541.HKD","SG9999014559.SGD","IE00BJJMRZ35.SGD","LU1093756168.USD","SG9999002232.USD","LU0861579265.USD","LU1066053197.SGD","RVMD","BK4585","LU0208291251.USD","LU2023250504.SGD","LU2023250843.SGD","LU0265550946.USD","LU1035773651.USD","LU0266013472.USD","SG9999001176.USD","IE00BLSP4452.SGD","LU0098860793.USD","LU1066051225.USD","LU0477156953.USD","BK4139","LU0289739699.SGD","LU1291159041.SGD","LU1989771016.USD","SG9999015358.SGD","LU0058720904.USD","BK4534","IE00BJT1NW94.SGD","LU1934455194.USD","LU1057294990.SGD","IE00BN8TJ469.HKD","LU1934455863.HKD","LU1066051498.USD","LU0106261372.USD","LU0122379950.USD","LU1116320737.USD","LU2361044865.SGD","LU0070302665.USD","LU0238689110.USD","SGXZ57979304.SGD","LU0234572021.USD","LU2468319806.SGD","LU2361045086.USD","LU1929549753.HKD","LU1023059063.AUD","LU1201861249.SGD","LU2461242641.AUD","LU0130102774.USD","LU1585245621.USD","LU1941712348.USD","LU1989772840.SGD","LU1989772923.USD","IE00B1BXHZ80.USD","LU1069347547.HKD","LU0965508806.USD","IE00B2B36J28.USD","LU1917777945.USD","SG9999001176.SGD","LU0965509101.SGD","BK4007","IE00B4R5TH58.HKD","LU2125154935.USD","LU1066051811.HKD","LU0980610538.SGD","SG9999014567.USD","LU2106854487.HKD","LU1116320901.HKD","LU2089984988.USD"],"gpt_icon":0},{"id":"2602230612","title":"STAT’s Adam Feuerstein says Revolution Medicines canceled meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2602230612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602230612?lang=en_us&edition=fundamental","pubTime":"2026-01-10 03:55","pubTimestamp":1767988522,"startTime":"0","endTime":"0","summary":"STAT’s Adam Feuerstein said viax that, “$RVMD – I had a meeting scheduled with the CEO on Monday morning. The company just cancelled. #JPM26 RevMed...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/stats-adam-feuerstein-says-revolution-medicines-canceled-meeting-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/stats-adam-feuerstein-says-revolution-medicines-canceled-meeting-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RVMD"],"gpt_icon":0},{"id":"2602305340","title":"Sector Update: Health Care Stocks Mixed Friday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2602305340","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602305340?lang=en_us&edition=fundamental","pubTime":"2026-01-10 02:32","pubTimestamp":1767983524,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index adding 0.1% and the State Street Health Care Select Sector SPDR ETF  fractionally lower.The iShares Biotechnology ETF  increased 0.5%.In corporate news, Merck  is in talks to buy Revolution Medicines , the Financial Times reported Thursday. The deal, which could be announced in several weeks, is likely to be valued between $28 billion and $32 billion, the report said. Merck shares rose 0.7%, and Revolution gained 4.2%.Amazon.com's  pharmacy unit said Friday it now offers the pill version of Novo Nordisk's  Wegovy through insurance plans and cash-pay options. Novo shares gained 3%.Liquidia  shares surged nearly 16% after it reported preliminary Q4 net sales of Yutrepia of about $90.1 million, bringing full-year 2025 net sales to $148.3 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0642271901.SGD","LU2083900584.USD","LU2552382058.USD","IE00BMPRXQ63.HKD","LU0158827948.USD","LU0077335932.USD","LU0149725797.USD","LU2092937148.SGD","BK4592","LU2381873111.SGD","LU0528227936.USD","LU0122379950.USD","SG9999017495.SGD","LU2242649171.HKD","LU2324357040.USD","MRK","LU0109391861.USD","LU1983299246.USD","LU2430703095.HKD","LU0689472784.USD","LU0215105999.USD","LU0130103400.USD","LU0965509010.AUD","IE00BQXX3C00.GBP","IE00BQXX3D17.EUR","LU2505996509.AUD","LU1861559042.SGD","LU2089984988.USD","IE0001KFT4U8.USD","LU0787776722.HKD","IE000ITXATA3.USD","BK4612","BK4585","IE00B2B36J28.USD","IE00BFXG0V08.USD","IE00B1XK9C88.USD","LU2471134879.HKD","LU2746668461.USD","LU2361045086.USD","LU2028103732.USD","LU1988902786.USD","IE00BJT1NW94.SGD","LU1548497426.USD","LU0070217475.USD","LU1934455194.USD","LU2023250843.SGD","LU1917777945.USD","LU1934455863.HKD","IE00B4JS1V06.HKD","LU0011850046.USD","LU2264538146.SGD","LU1074936037.SGD","LU2430703251.USD","LU0823411888.USD","IE0009355771.USD","SG9999014898.SGD","LU2430703178.SGD","LU0157215616.USD","LU2087621335.USD","LU2237957811.SGD","LU2452424414.USD","LU2360032135.SGD","RVMD","LU1316542783.SGD","LU0345770308.USD","LU0345769128.USD","IE00BKVL7J92.USD","LU0683600562.USD","LU1791710582.SGD","SG9999000418.SGD","LU0128525929.USD","LU2720916845.USD","BK4581","LU0985320562.USD","LU2077746001.SGD","LU0345768740.USD","LU2065171311.SGD","LU0170899867.USD","IE00BJLML261.HKD","LU0061475181.USD","LU1585245621.USD","LU1839511570.USD","LU2023250504.SGD","LU0820562030.AUD","LU2063271972.USD","LU0820561909.HKD","SG9999013999.USD","LU0823421416.USD","IE00BMPRXN33.USD","LU1084165304.USD","LU0456855351.SGD","LU1037948541.HKD","LU1037948897.HKD","LU1145028129.USD","LU0354030438.USD","LU1061106388.HKD","LU0162691827.USD","LU2860962120.EUR","LU0211327993.USD","LU1720051108.HKD","LU1496350502.SGD","LU0203202063.USD","LU1366333091.USD","LU2326559502.SGD","IE0004086264.USD","SGXZ99366536.SGD","IE00BJTD4V19.USD","LU0098860793.USD","SG9999014567.USD","LU0267386448.USD","LU0964807845.USD","LU2468319806.SGD","LU0354030511.USD","LU0342679015.USD","IE00BLSP4452.SGD","LU2065170008.USD","LU1674673691.USD","IE00BN8TJ469.HKD","LU1929549753.HKD","SGXZ51526630.SGD","LU1935043536.SGD","LU0203347892.USD","LU2764263203.CNY","IE00BK4W5L77.USD","LU2250418816.HKD","LU0266013472.USD","SG9999018857.SGD","LU0238689110.USD","LU1201861165.SGD","LU1551013342.USD","BK4543","LU2168564495.EUR","LU2023250330.USD","LU1718418525.SGD","LU0323591593.USD","IE0004091025.USD","IE00B4R5TH58.HKD","SG9999015952.SGD","LU0320765646.SGD","LU1066053197.SGD","IE0004445015.USD","BK4550","BK4516","LU1267930573.SGD","IE0004445239.USD","LU2471134796.USD","IE00B775H168.HKD","LU0861579265.USD","BK4598","LU0353189763.USD","LU1323610961.USD","LU0127658192.USD","LU0788109477.HKD","SG9999014575.USD","LU0061474705.USD","LU0320765059.SGD","LU2417539215.USD","LU0029864427.USD","LU2065169927.USD","LU0107464264.USD","BK4561","LU1093756325.SGD","BK4538","LU1244550494.USD","SGXZ31699556.SGD","LU1691799644.USD","LU0072461881.USD","SG9999002232.USD","LU0648000940.SGD","LU0320765489.SGD","LU2764263039.SGD","BK4579","LU1162221912.USD","LU1883839398.USD","LU1201861249.SGD","LU0390134368.USD","LU2125154778.USD","LU0251132253.USD","LU0082616367.USD","LU1035773651.USD","IE00B7KXQ091.USD","LU2461242641.AUD","LU0310800379.SGD","LU1815333072.USD","LU0314104364.USD","LU1935043023.USD","LU0211328371.USD","LU1803068979.SGD","LU1035775433.USD","LU0345769631.USD","LU0708994859.HKD","LU1069344957.HKD","LU1633808545.USD","LU1674673428.USD","SG9999015945.SGD","USAW.SI","LU2023251221.USD","LU0316494557.USD","LU1868836914.USD","LU0096364046.USD","BK7104","LU1935042215.USD","LU2362541273.HKD","LU1291159041.SGD","BK4220","LU1868836757.USD","LU0211331839.USD","LU2247934214.USD","LU1430594728.SGD","LU2750360641.GBP","LU2357305700.SGD","LU0006306889.USD","XBI","LU2420271590.USD","SGXZ23171101.USD","LU1804176565.USD","IE00B3S45H60.SGD","LU1868837136.USD","SG9999014559.SGD","LU1066051225.USD","LU1629891620.HKD","LU2317271919.USD","GB00BDT5M118.USD","BK4566","IE00BLSP4239.USD","LU0056508442.USD","LU1989764748.USD","LU0058720904.USD","IE000W1ABFV2.USD","LU1941712264.USD","LU0265550946.USD","LU0345774631.USD","SG9999002224.SGD","LU1244550221.USD","LU1880398554.USD","LU0348723411.USD","LU1023059063.AUD","LU0345770993.USD","LU0130102774.USD","LU1861127337.USD","BK4588","LU0724617625.USD","LU0234572021.USD","LU0786609619.USD","IE00BFTCPJ56.SGD","LU1974910355.USD","LU2750360997.AUD","LU2092627202.USD","LU1116320901.HKD","BK4139","LU0889565833.HKD","SG9999015986.USD","IE00B3SWFQ91.USD","IE00BSNM7G36.USD","SG9999015341.SGD","LU2271345857.HKD","LU0289739699.SGD","LU0208291251.USD","SG9999014906.USD","LU1989772923.USD","LU1868836591.USD","LU2108987350.USD","LU0256863811.USD","LU2089284900.SGD","LU2552382215.SGD","SG9999014880.SGD","LU0965508806.USD","IE0034235303.USD","LU1571399168.USD","LU2764262908.HKD","BK4503","SG9999015978.USD","LU2211815571.USD","LU0466842654.USD","LU0256863902.USD","LU0203345920.USD","IE00B4YYXB79.USD","LU0109392836.USD","LU2471134952.CNY","HK0000914686.HKD","LU0276348264.USD","LU0072462426.USD","LU2403377893.USD","LU1934455277.USD","IE00BFSS8Q28.SGD","LU2236285917.USD","LU0079474960.USD","LU0130517989.USD","LU0158827781.USD","LU0210536198.USD","LU0289941410.SGD","IE00BK4W5M84.HKD","LU2211817866.USD","LU2237957902.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","LU2111349929.HKD","LU2361044949.HKD","LU0198837287.USD","LU2168563687.JPY","LU0097036916.USD","LU2602419157.SGD","LU0345768153.USD","LU0640476718.USD","LU1435385759.SGD","IE0005OL40V9.USD","LU0417517546.SGD","LU0312595415.SGD","LU0965509283.SGD","LU1861558580.USD","BK4534","LU2552382132.HKD","IE00BFSS7M15.SGD","LU0820561818.USD","LU1720051017.SGD","LU1880398471.USD","LU2896262040.SGD","LU0302445910.USD","SG9999014542.SGD","LU1244550577.SGD","LU0308772762.SGD","LU2505996681.GBP","IE00BJTD4N35.SGD","LU1057294990.SGD","IE00B7SZLL34.SGD","SG9999004303.SGD","LU1093756168.USD","LU0070302665.USD","BK4599","LU0353189680.USD","IE00BJJMRY28.SGD","LU2168564149.EUR","LU0965509101.SGD","LU1046421795.USD","LU1791710400.SGD","SG9999018865.SGD","LU0957791311.USD","IE00B5949003.HKD","LU1941712348.USD","LU2097829019.USD","LU0265550359.USD","LU1699723380.USD","LU0719512351.SGD","LU2462157665.USD","LU2756315664.SGD","IE00BKDWB100.SGD","LU1280957306.USD","LU0080751232.USD","LU2471134523.USD","LU0210528500.USD","IE00B1BXHZ80.USD","LU0823434583.USD","IE000M9KFDE8.USD","IE00B775SV38.USD","HK0000914660.USD","BK4527","LU1868837300.USD","LU2242650005.HKD","SG9999001077.SGD","LU1814569148.SGD","BK4551","IE00BJJMRX11.SGD","IE00B19Z8W00.USD","LU2089283258.USD","LU2756315318.SGD","IE00B19Z8X17.USD","LU1153585028.USD","LU1235294995.USD","BK4507","BK4554","LU1069347547.HKD","LU2106854487.HKD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0203201768.USD","LU0048584097.USD","LU2361044865.SGD","IE000YTNTUN2.SGD","LU1232071149.USD","LU2275660780.HKD","BK4007","LU0061474960.USD","LU1366192091.USD","LU1935042991.SGD","BK4596","LU2168564065.EUR","IE00BZ1G4Q59.USD","LU2087625088.SGD","LU1989764664.SGD","LU2213496289.HKD","SGXZ81514606.USD","LU2543165471.USD","BK4548","IE0009G5SDU7.USD","LU0823421333.USD","LU1429558221.USD","LU1989771016.USD","LU0106261372.USD","LU0477156953.USD","LU0708995401.HKD","LU0672654240.SGD","IE0002141913.USD","LU2065171402.SGD","LU2054465674.USD","LU2487616109.SGD","LU2112291526.USD","LU1127390331.HKD","LU0980610538.SGD","LU2362541513.USD","IE00BKPKM429.USD","LU1935042488.USD","SG9999014914.USD","LU0310799852.SGD","LU2362540622.SGD","LU0210533765.USD","LU0648001328.SGD","IE00BN29S564.USD","LU1116320737.USD","LU1064131342.USD","SG9999001440.SGD","LU2168564222.USD","LU1267930730.SGD","IE00B5TLWC47.USD","LU1261432733.SGD","IE0002270589.USD","LU1852331112.SGD","LABU","BK4532","IE0003U64NQ7.SGD","LU2592432038.USD","LU0234570918.USD","LU1066051811.HKD","LU1066051498.USD","LU1267930490.SGD","LU1119994496.HKD","LU1496350171.SGD","LU1989772840.SGD","LU1551013425.SGD","LU0494093205.USD","IE00BBT3K403.USD","LU0823434740.USD","SGXZ57979304.SGD","LU2237438978.USD","IE00BWXC8680.SGD","LU2360106780.USD","IE0009356076.USD","LU2463028550.USD","IE00B19Z9505.USD","IE00BYQQ9H92.USD","SG9999015358.SGD","BK4122","LU2456880835.USD","LU0943347566.SGD","BK4535","SG9999001176.SGD","LU0345774391.USD","IE00BMPRXR70.SGD","LU0289960550.SGD","BK4559","BK4533","LU1823568750.SGD","LU0053666078.USD","LU2125154935.USD","LU2265009873.SGD","LU0096362180.USD","IE00BQXX3F31.USD","LU1914381329.SGD","IE000KEQY171.SGD","BK4604","LU2746668974.SGD","LU1778281490.HKD","BK4524","LU0175139822.USD","LU0154236417.USD","LU0882574139.USD"],"gpt_icon":0},{"id":"2602354308","title":"Top Midday Stories: December Jobs Data Undershoots Expectations; Meta Signs Nuclear Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2602354308","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602354308?lang=en_us&edition=fundamental","pubTime":"2026-01-10 00:49","pubTimestamp":1767977355,"startTime":"0","endTime":"0","summary":"All three major US stock indexes were up in late-morning trading Friday, after the US Bureau of Labor Statistics issued the latest employment data, which undershot expectations.The December jobs repor","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B775H168.HKD","LU2023250504.SGD","SG9999015978.USD","LU0985320562.USD","LU1064131342.USD","GB00BDT5M118.USD","LU1366333091.USD","LU1585245621.USD","LU0077335932.USD","LU1366192091.USD","IE00BK4W5M84.HKD","LU1868837136.USD","SG9999001077.SGD","LU0719512351.SGD","LU0162691827.USD","IE00BZ18W456.USD","LU0648000940.SGD","IE00B5TLWC47.USD","IE00B19Z3B42.SGD","LU1244550494.USD","LU0029864427.USD","LU2111349929.HKD","LU0345774391.USD","BK4592","LU2505996509.AUD","LU0320765489.SGD","LU0661504455.SGD","IE00BWXC8680.SGD","SG9999014559.SGD","LU1988902786.USD","IE00BKPKM429.USD","LU1242518857.USD","LU1057294990.SGD","LU1267930730.SGD","LU0949170426.SGD","LU1917777945.USD","LU2272731865.HKD","SG9999014575.USD","LU0170899867.USD","LU2097829019.USD","IE0009355771.USD","IE00BK4W5L77.USD","IE00B775SV38.USD","LU0308772762.SGD","LU0823434740.USD","LU0354030438.USD","LU2089984988.USD","LU2471134796.USD","LU0203202063.USD","LU1989772923.USD","LU2458330243.SGD","BK4548","LU1046421795.USD","IE00BFMHRM44.USD","LU2250418816.HKD","LU0354030511.USD","BK4612","IE0002270589.USD","SG9999014914.USD","SG9999002224.SGD","BK4588","META","LU1697837992.HKD","LU2361044865.SGD","LU2403377893.USD","LU1435385759.SGD","LU2028103732.USD","IE000ITXATA3.USD","SG9999015986.USD","BK4516","BK4551","LU0070217475.USD","LU1868836914.USD","LU1496350502.SGD","LU0267386448.USD","LU0211331839.USD","LU2083900584.USD","LU2092937148.SGD","USAW.SI","LU1429558221.USD","LU0097036916.USD","BK4581","LU1116320737.USD","IE00BLSP4452.SGD","LU0210536198.USD","LU1880398471.USD","LU2242649171.HKD","LU1732799900.SGD","IE00BQXX3D17.EUR","LU0476273544.USD","LU0011850046.USD","LU0058720904.USD","LU1261432733.SGD","LU0061475181.USD","LU2065169927.USD","LU2471134952.CNY","LU2247934214.USD","IE0034235188.USD","BK4527","BK4534","LU2360032135.SGD","SGXZ23171101.USD","LU1914381329.SGD","LU2860962120.EUR","SG9999014880.SGD","LU1145028129.USD","LU0203345920.USD","LU0128525929.USD","LU0109392836.USD","LU0795875169.SGD","LU0820561818.USD","LU2242650005.HKD","IE00BJTD4V19.USD","LU0690374961.EUR","LU2381873111.SGD","LU0203201768.USD","LU0211327993.USD","LU0979878070.USD","LU1201861165.SGD","LU0256863902.USD","LU0289739699.SGD","LU2750360997.AUD","LU0823421333.USD","LU1244550577.SGD","LU1548497426.USD","IE00BKDWB100.SGD","LU0234570918.USD","LU2092627202.USD","IE00B4JS1V06.HKD","LU1989764664.SGD","LU0312595415.SGD","IE00BMPRXQ63.HKD","BK7511","LU1316542783.SGD","LU1935042488.USD","LU0494093205.USD","IE000KEQY171.SGD","LU1670710661.SGD","LU0210528500.USD","IE00B4YYXB79.USD","LU0130102774.USD","LU0708994859.HKD","LU2462157665.USD","LU1564329461.SGD","LU1127390331.HKD","BK4559","LU0433182093.SGD","LU1323610961.USD","LU0912757837.SGD","IE00B1BXHZ80.USD","SG9999000418.SGD","LU1935042215.USD","LU1852331112.SGD","LU0672654240.SGD","LU0345770993.USD","LU1803068979.SGD","LU0353189680.USD","LU0061474960.USD","SG9999018857.SGD","LU1670711040.USD","SG9999001440.SGD","LU2552382215.SGD","LU0203347892.USD","LU1201861249.SGD","LU2764262908.HKD","LU1674673428.USD","LU2322448791.USD","BK4105","LU0786609619.USD","LU2361044949.HKD","LU2275660780.HKD","LU0957808578.USD","LU0122379950.USD","LU2473716301.USD","SGXZ31699556.SGD","LU0175139822.USD","LU0098860793.USD","LU0985489474.SGD","LU1883839398.USD","LU1691799644.USD","LU1791710400.SGD","LU1934455277.USD","LU0345769128.USD","LU1670710588.SGD","LU1718418525.SGD","LU2272731600.USD","LU0157215616.USD","LU2452424414.USD","LU0820561909.HKD","LU1791710582.SGD","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU2322448957.HKD","LU0949170772.SGD","LU0276348264.USD","LU2471134879.HKD","LU1992135472.HKD","LU0784385840.USD","LU2750360641.GBP","BK4503","LU1430594728.SGD","LU1069344957.HKD","IE00BBT3K403.USD","LU0215105999.USD","LU1551013425.SGD","LU0302445910.USD","LU1941712348.USD","LU1267930490.SGD","BK4532","LU0823421416.USD","IE00B19Z9505.USD","IE00B19Z8W00.USD","LU2065170008.USD","LU0738911758.USD","HK0000914660.USD","LU0823434583.USD","LU0444971666.USD","LU2063271972.USD","SG9999001176.SGD","LU0878866978.SGD","LU1992135399.USD","SG9999017495.SGD","LU0784384876.USD","LU0265550359.USD","IE00B3S45H60.SGD","LU2360106780.USD","SG9999014567.USD","LU2089283258.USD","BK4122","LU0320765059.SGD","LU2317271919.USD","BK4598","LU0225283273.USD","SGXZ57979304.SGD","LU1119994496.HKD","IE000W1ABFV2.USD","IE00BJT1NW94.SGD","LU1564329115.USD","IE00B7SZLL34.SGD","IE0004086264.USD","BK4579","LU2552382058.USD","LU0444973449.USD","LU0820562030.AUD","IE00B3SWFQ91.USD","LU0256863811.USD","BK4139","LU2108987350.USD","LU2213496289.HKD","LU0683600562.USD","LU2211817866.USD","LU2420271590.USD","IE0004091025.USD","LU2168564495.EUR","LU0053666078.USD","LU1564329628.SGD","BK4554","LU1116320901.HKD","BK4168","LU0345768740.USD","BK4550","LU0528227936.USD","LU2417539215.USD","BK4077","LU0642271901.SGD","LU1571399168.USD","LU1804176565.USD","LU0320765646.SGD","LU1153585028.USD","LU1551013342.USD","BK4561","LU1093756325.SGD","LU2592432038.USD","LU1868837300.USD","LU0882574139.USD","LU1066053197.SGD","SG9999001176.USD","LU1934455194.USD","LU1974910355.USD","LU2065171311.SGD","SG9999014542.SGD","LU2264538146.SGD","LU2357305700.SGD","LU0080751232.USD","LU1732800096.USD","LU0345769631.USD","LU2468319806.SGD","LU1037948897.HKD","IE00BJJMRY28.SGD","LU1815333072.USD","LU2461242641.AUD","LU0154236417.USD","IE00BLSP4239.USD","LU0210533765.USD","LU0466842654.USD","LU1242518931.SGD","LU0345768153.USD","LU0096362180.USD","LU0640476718.USD","LU0208291251.USD","LU0545039389.USD","LU1778281490.HKD","SG9999004303.SGD","LU2077746001.SGD","LU2552382132.HKD","IE0034235303.USD","LU1934455863.HKD","BK4585","LU0266013472.USD","LU1489326972.SGD","LU0553294199.USD","IE00BFSS8Q28.SGD","LU2746668974.SGD","LU0072461881.USD","LU0861579265.USD","IE00BQXX3C00.GBP","LU2347655156.SGD","BK7507","LU1066051498.USD","IE0001KFT4U8.USD","LU2602419157.SGD","LU0788109477.HKD","SG9999015952.SGD","LU2168564149.EUR","LU2326559502.SGD","LU2168564065.EUR","IE00B19Z8X17.USD","IE0005OL40V9.USD","LU0314104364.USD","IE00BN29S564.USD","BK4599","BK4596","LU0198837287.USD","LU0708995401.HKD","LU0323591593.USD","SG9999013999.USD","LU1814569148.SGD","LU0353189763.USD","LU2543165471.USD","LU1564329032.USD","LU2756315664.SGD","LU1061106388.HKD","LU0690374615.EUR","LU0289941410.SGD","LU0965508806.USD","LU1861559042.SGD","LU2237438978.USD","SGXZ51526630.SGD","LU1496350171.SGD","BK4535","LU2112291526.USD","LU2362540622.SGD","LU2133065610.SGD","LU2023250330.USD","LU2430703178.SGD","IE0003U64NQ7.SGD","SG9999002232.USD","IE000M9KFDE8.USD","LU1720051017.SGD","LU1642822529.SGD","SGXZ81514606.USD","LU0345770308.USD","IE00BSNM7G36.USD","LU1035775433.USD","LU2237957902.USD","BK4604","LU0072462426.USD","LU2764263039.SGD","LU0345774631.USD","LU0234572021.USD","VST","BK4606","LU1074936037.SGD","IE00BJLML261.HKD","SG9999015945.SGD","LU0943347566.SGD","LU1232071149.USD","LU0096364046.USD","LU0784385170.HKD","LU0251132253.USD","LU0006306889.USD","LU0310800379.SGD","SG9999014906.USD","LU0348723411.USD","BK4220","IE0009356076.USD","LU0107464264.USD","LU2272731782.SGD","BK4587","IE00BQXX3F31.USD","LU1861558580.USD","LU0823411888.USD","LU0957791311.USD","LU2125154935.USD","LU1003077747.HKD","LU1880398554.USD","LU1244550221.USD","LU0456855351.SGD","LU2125154778.USD","IE00B5949003.HKD","LU1066051811.HKD","LU2362541513.USD","IE00BYQQ9H92.USD","BK7104","LU0238689110.USD","LU1066051225.USD","LU2764263203.CNY","LU2168563687.JPY","LU2458330169.SGD","IE00BMQBXF63.USD","LU0648001328.SGD","LU1868836591.USD","LU2463028550.USD","SG9999018865.SGD","LU0889565833.HKD","IE0009G5SDU7.USD","LU2361045086.USD","IE000YTNTUN2.SGD","LU2023250843.SGD","LU0726765562.USD","IE0004445239.USD","LU1699723380.USD","LU2054465674.USD","LU1670627923.USD","LU2087621335.USD","LU2265009873.SGD","LU0965509010.AUD","LU0070302665.USD","IE00B1XK9C88.USD","LU1035773651.USD","LU1815336760.USD","IE00BJJMRZ35.SGD","LU1674673691.USD","LU1941712264.USD","LU2271345857.HKD","LU0158827781.USD","RVMD","LU1084165304.USD","LU2487616109.SGD","IE00BZ1G4Q59.USD","LU2065171402.SGD","LU0061474705.USD","LU0130517989.USD","GB00B4QBRK32.GBP","LU1093756168.USD","LU1629891620.HKD","LU0316494557.USD","LU1280957306.USD","LU1989764748.USD","LU0106261372.USD","LU0079474960.USD","LU0149725797.USD","LU0342679015.USD","LU1670711123.USD","LU2089284900.SGD","LU2404859667.USD","LU2023251221.USD","IE00BJJMRX11.SGD","LU1823568750.SGD","LU0724617625.USD","LU0310799852.SGD","LU1235294995.USD","LU0068578508.USD","IE0004445015.USD","IE00BFXG0V08.USD","BK4507","LU0289960550.SGD","LU1023059063.AUD","IE00BFTCPJ56.SGD","IE00BFSS7M15.SGD","LU2211815571.USD","SG9999015358.SGD","IE00B4R5TH58.HKD","IE00BN8TJ469.HKD","LU1868836757.USD","LU2404859741.USD","MRK","LU0477156953.USD","BK4538","BK4524","LU2756315318.SGD","LU2430703251.USD","LU0082616367.USD","LU0127658192.USD","LU0787776722.HKD","IE00BJTD4N35.SGD","LU0784383803.USD","LU2237957811.SGD","LU2430703095.HKD","LU0158827948.USD","IE00B7KXQ091.USD","SG9999015341.SGD","LU2746668461.USD","LU1983299246.USD","LU0689472784.USD","IE0002141913.USD","SGXZ99366536.SGD","LU1670628061.USD","LU2456880835.USD","LU1935043536.SGD","LU2087625088.SGD","LU0390134368.USD","LU1861127337.USD","LU1989772840.SGD","GB00B4LPDJ14.GBP","LU2896262040.SGD","LU1935043023.USD","LU1633808545.USD","LU1720051108.HKD","LU1839511570.USD","LU0965509101.SGD","LU2347655073.USD","LU0130103400.USD","LU1301847155.USD","LU2106854487.HKD","LU0109391861.USD","LU1037948541.HKD","BK4533","BK7095","LU2505996681.GBP","HK0000914686.HKD","IE00BZ18W340.USD","LU0980610538.SGD","LU2236285917.USD","LU1929549753.HKD","LU0048584097.USD","IE00BMPRXR70.SGD","LU2362541273.HKD","SG9999014898.SGD","LU0965509283.SGD","LU1989771016.USD","LU2324357040.USD","LU1069347547.HKD","LU2168564222.USD","LU2471134523.USD","LU0265550946.USD","BK4007","LU0964807845.USD","LU2720916845.USD","LU1162221912.USD","LU1267930573.SGD","IE00B2B36J28.USD","IE00BMPRXN33.USD","LU0211328371.USD","BK4566","LU0795875086.SGD","BK4543","LU0417517546.SGD","LU0056508442.USD","LU1291159041.SGD","LU1935042991.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revmed.com","stockEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":0.4752},{"period":"3month","weight":1.1937},{"period":"6month","weight":2.1225},{"period":"1year","weight":1.8846},{"period":"ytd","weight":0.4591}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0044},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.068},{"period":"1year","weight":0.1339},{"period":"ytd","weight":-0.0064}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Revolution Medicines, Inc., a clinical-stage oncology company, developing novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) Inhibitors designed to suppress oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. The company's RAS(ON) Inhibitors RMC-6236 (RASMULTI), RMC-6291 (RASG12C), and RMC-9805 (RASG12D) are in clinical development. Its additional RAS(ON) Inhibitors in its pipeline include RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), which are in IND-enabling development, and additional compounds targeting other RAS variants. The company has a collaboration agreement with Sanofi for the research and development of SHP2 inhibitors, including RMC-4630. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.075105},{"month":2,"riseRate":0.6,"avgChangeRate":-0.005035},{"month":3,"riseRate":0.5,"avgChangeRate":-0.029333},{"month":4,"riseRate":0.666667,"avgChangeRate":0.052764},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.03349},{"month":6,"riseRate":0.833333,"avgChangeRate":0.042659},{"month":7,"riseRate":0.5,"avgChangeRate":-0.000709},{"month":8,"riseRate":0.666667,"avgChangeRate":0.059948},{"month":9,"riseRate":0.5,"avgChangeRate":0.038151},{"month":10,"riseRate":0.666667,"avgChangeRate":0.019949},{"month":11,"riseRate":0.833333,"avgChangeRate":0.188424},{"month":12,"riseRate":0.5,"avgChangeRate":-0.027192}],"exchange":"NASDAQ","name":"Revolution Medicines, Inc.","nameEN":"Revolution Medicines, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revolution Medicines, Inc.(RVMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Revolution Medicines, Inc.(RVMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Revolution Medicines, Inc.,RVMD,Revolution Medicines, Inc.股票,Revolution Medicines, Inc.股票老虎,Revolution Medicines, Inc.股票老虎国际,Revolution Medicines, Inc.行情,Revolution Medicines, Inc.股票行情,Revolution Medicines, Inc.股价,Revolution Medicines, Inc.股市,Revolution Medicines, Inc.股票价格,Revolution Medicines, Inc.股票交易,Revolution Medicines, Inc.股票购买,Revolution Medicines, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revolution Medicines, Inc.(RVMD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Revolution Medicines, Inc.(RVMD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}